YACHMETZ PHILIP K
Insider CIK 1250318 · TLGT EVP, Chief Legal Off, Corp Sec · SVNT SVP, General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TLGT Teligent, Inc. | M Exercise deriv | 2021-07-16 | 2021-07-20 | 7,835 | — | $0 | 15,670 | SEC↗ |
| TLGT Teligent, Inc. | M Exercise deriv | 2021-07-16 | 2021-07-20 | 7,835 | — | $0 | 15,670 | SEC↗ |
| TLGT Teligent, Inc. | M Exercise | 2021-07-16 | 2021-07-20 | 7,835 | — | $0 | 7,835 | SEC↗ |
| TLGT Teligent, Inc. | F Tax w/h | 2021-07-16 | 2021-07-20 | 2,656 | $0.47 | $1.2K | 5,176 | SEC↗ |
| TLGT Teligent, Inc. | M Exercise | 2021-07-16 | 2021-07-20 | 7,835 | — | $0 | 7,835 | SEC↗ |
| TLGT Teligent, Inc. | F Tax w/h | 2021-07-16 | 2021-07-20 | 2,656 | $0.47 | $1.2K | 5,179 | SEC↗ |
| TLGT Teligent, Inc. | A Award deriv | 2021-03-11 | 2021-03-15 | 344,000 | — | $0 | 344,400 | SEC↗ |
| TLGT Teligent, Inc. | A Award deriv | 2021-03-11 | 2021-03-15 | 424,000 | — | $0 | 424,000 | SEC↗ |
| TLGT Teligent, Inc. | A Award deriv | 2020-07-16 | 2020-07-17 | 36,325 | — | $0 | 36,325 | SEC↗ |
| TLGT Teligent, Inc. | A Award deriv | 2020-07-16 | 2020-07-17 | 23,505 | — | $0 | 23,505 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-10-15 | 2013-10-17 | 10,000 | $0.09 | $900 | 90,545 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-10-15 | 2013-10-17 | 20,000 | $0.10 | $2.0K | 283,701 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-10-15 | 2013-10-17 | 19,745 | $0.10 | $2.0K | 263,956 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-10-15 | 2013-10-17 | 20,000 | $0.09 | $1.8K | 243,956 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-10-15 | 2013-10-17 | 40,000 | $0.10 | $4.0K | 203,956 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-10-15 | 2013-10-17 | 53,411 | $0.10 | $5.3K | 100,545 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-10-15 | 2013-10-17 | 50,000 | $0.10 | $5.0K | 153,956 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | A Award deriv | 2013-03-05 | 2013-03-07 | 110,000 | — | $0 | 110,000 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | A Award deriv | 2013-03-05 | 2013-03-07 | 78,000 | — | $0 | 78,000 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-02-04 | 2013-02-06 | 3,203 | $1.02 | $3.3K | 303,701 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-02-04 | 2013-02-06 | 27,297 | $1.01 | $27.6K | 306,904 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-01-14 | 2013-01-16 | 1,283 | $1.14 | $1.5K | 334,201 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | A Award | 2012-02-27 | 2012-02-29 | 100,000 | $2.10 | $210.0K | 335,484 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2012-02-14 | 2012-02-23 | 3,540 | $2.02 | $7.2K | 235,484 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | A Award deriv | 2012-02-01 | 2012-02-13 | 100,000 | $2.26 | $226.0K | 100,000 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | A Award | 2012-02-01 | 2012-02-13 | 50,000 | $2.26 | $113.0K | 239,024 | SEC↗ |